PhoenixBio Co (6190.T) Stock Price

PhoenixBio Co Price

CLOSED
305.00
+0.00 (+0.00 %)
Market closed

Over the last 11 years PhoenixBio Co grew revenue by 2.7% annually, reaching 1.54 B JPY. Earnings per share have declined at 18.1% per year over the last 10 years. For PhoenixBio Co, the net margin of -29.1% is down versus -23.5% a few years ago. The stock trades about 2% above its 52-week low.

PhoenixBio Co stock price

Access this data via the Eulerpool API

PhoenixBio Co business model & stock analysis

Frequently asked questions about PhoenixBio Co

Converted at the current exchange rate, the PhoenixBio Co share trades at 1.70 EUR (305.00 JPY).

No history available for PhoenixBio Co.

The revenue cannot currently be calculated for PhoenixBio Co.

The profit cannot currently be calculated for PhoenixBio Co.

The P/E ratio cannot be calculated for PhoenixBio Co at the moment.

The P/S cannot be calculated for PhoenixBio Co currently.

The Eulerpool Quality Score for PhoenixBio Co is 2/10.

The ISIN of PhoenixBio Co is JP3803010002. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of PhoenixBio Co is 6190.T. The ticker symbol is used to trade PhoenixBio Co shares on the stock exchange.

PhoenixBio Co paid dividends every year for the past 0 years.

PhoenixBio Co is assigned to the 'Health' sector.

The dividends of PhoenixBio Co are distributed in JPY.

Fair ValueTerminal
259.25 JPY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Life Sciences Tools & Services
Number of shares
Employees
Revenue per Employee
23.71 M JPY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
JPY
Initial public offering
Mar 18, 2016
ISIN
JP3803010002
Cusip
J6S66Z100
Market capitalization
1.24 B JPYSmall Cap
52-Week Range
300.00–678.00JPY
Revenue growth (10Y) > 5%
Revenue growth (3Y) > 5 %
EBIT growth (10Y) > 5%
EBIT growth (3Y) > 5 %
Net debt < 4x EBIT
Profitable since 10Y+
EBIT Drawdown (10Y) < 50%
Return on Equity (ROE) > 15%
ROCE > 15%
Return Expectation > 10%
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.91
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-23.25 %
Gross Margin
72.51 %
EBIT Margin
-9.22 %
Net Margin
-29.13 %
EPS (Earnings Per Share)
-111.00 JPY
Net Debt / EBIT
4.11
Debt/Equity
0.41
Last updated Sep 27, 2026, 2:51 PM

PhoenixBio Co Peer Group

PhoenixBio Co FIGI

6190:JP · BBG002PKQYK86190:JT · BBG00C7LV2006190:JJ · BBG00C7LV2916190:JE · BBG00C7LV2D66190:JI · BBG00C7LV2F46190:JU · BBG00C7LV2G36190:JW · BBG00C7LV2H26190:JV · BBG0193RCSK9

All fundamentals and in-depth analysis of PhoenixBio Co

Our stock analysis for PhoenixBio Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PhoenixBio Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.